HYDROCHLOROTHIAZIDE\SPIRONOLACTONE: 185 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
185
Total FAERS Reports
3 (1.6%)
Deaths Reported
78
Hospitalizations
185
As Primary/Secondary Suspect
13
Life-Threatening
First Report: 1956 · Latest Report: 20241206
What Are the Most Common HYDROCHLOROTHIAZIDE\SPIRONOLACTONE Side Effects?
#1 Most Reported
Ejection fraction decreased
39 reports (21.1%)
#2 Most Reported
Cardiac failure congestive
39 reports (21.1%)
#3 Most Reported
Off label use
38 reports (20.5%)
All HYDROCHLOROTHIAZIDE\SPIRONOLACTONE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Cardiac failure congestive | 39 | 21.1% | 0 | 38 |
| Ejection fraction decreased | 39 | 21.1% | 0 | 38 |
| Off label use | 38 | 20.5% | 0 | 31 |
| Fatigue | 30 | 16.2% | 0 | 10 |
| Diabetes mellitus | 22 | 11.9% | 0 | 0 |
| Abdominal distension | 21 | 11.4% | 0 | 4 |
| Oedema peripheral | 21 | 11.4% | 0 | 4 |
| Hypertension | 19 | 10.3% | 0 | 0 |
| Blood pressure decreased | 18 | 9.7% | 0 | 0 |
| Hyperuricaemia | 17 | 9.2% | 0 | 0 |
| Obesity | 17 | 9.2% | 0 | 0 |
| Dehydration | 16 | 8.7% | 0 | 9 |
| Type v hyperlipidaemia | 16 | 8.7% | 0 | 0 |
| Nausea | 13 | 7.0% | 0 | 7 |
| Dizziness | 12 | 6.5% | 0 | 10 |
| Drug hypersensitivity | 12 | 6.5% | 0 | 0 |
| Drug ineffective | 12 | 6.5% | 0 | 5 |
| Malaise | 11 | 6.0% | 0 | 8 |
| Arrhythmia | 10 | 5.4% | 0 | 9 |
| Dyspnoea | 10 | 5.4% | 0 | 9 |
Who Reports HYDROCHLOROTHIAZIDE\SPIRONOLACTONE Side Effects? Age & Gender Data
Gender: 42.7% female, 57.3% male. Average age: 66.3 years. Most reports from: US. View detailed demographics →
Is HYDROCHLOROTHIAZIDE\SPIRONOLACTONE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2002 | 2 | 0 | 2 |
| 2003 | 1 | 0 | 0 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 0 |
| 2014 | 12 | 0 | 4 |
| 2015 | 2 | 0 | 2 |
| 2016 | 6 | 0 | 2 |
| 2017 | 3 | 0 | 1 |
| 2018 | 5 | 0 | 1 |
| 2019 | 2 | 0 | 1 |
| 2020 | 2 | 0 | 1 |
| 2021 | 3 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
| 2023 | 1 | 0 | 0 |
| 2024 | 4 | 0 | 3 |
What Is HYDROCHLOROTHIAZIDE\SPIRONOLACTONE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 75 |
| Hypertension | 27 |
| Diuretic therapy | 7 |
| Psoriatic arthropathy | 5 |
HYDROCHLOROTHIAZIDE\SPIRONOLACTONE vs Alternatives: Which Is Safer?
HYDROCHLOROTHIAZIDE\SPIRONOLACTONE vs HYDROCHLOROTHIAZIDE\TELMISARTAN
HYDROCHLOROTHIAZIDE\SPIRONOLACTONE vs HYDROCHLOROTHIAZIDE\TRIAMTERENE
HYDROCHLOROTHIAZIDE\SPIRONOLACTONE vs HYDROCHLOROTHIAZIDE\VALSARTAN
HYDROCHLOROTHIAZIDE\SPIRONOLACTONE vs HYDROCODONE
HYDROCHLOROTHIAZIDE\SPIRONOLACTONE vs HYDROCODONE/ACETAMINOPHEN
HYDROCHLOROTHIAZIDE\SPIRONOLACTONE vs HYDROCODONE\IBUPROFEN
HYDROCHLOROTHIAZIDE\SPIRONOLACTONE vs HYDROCODONE+PARACETAMOL
HYDROCHLOROTHIAZIDE\SPIRONOLACTONE vs HYDROCORTISONE
HYDROCHLOROTHIAZIDE\SPIRONOLACTONE vs HYDROCORTISONE PROBUTATE
HYDROCHLOROTHIAZIDE\SPIRONOLACTONE vs HYDROCORTISONE\HYDROCORTISONE
Official FDA Label for HYDROCHLOROTHIAZIDE\SPIRONOLACTONE
Official prescribing information from the FDA-approved drug label.